Answers are grounded in this paper and cite their sources.
Ferroptosis, an iron-dependent form of regulated cell death driven by lipid peroxidation, has emerged as a critical mechanism in tumor suppression and a promising target for cancer therapy. As a reversible and dynamic post-translational modification, phosphorylation orchestrated by protein kinases serves as a pivotal regulatory layer in the ferroptotic process. This review systematically delineates the roles of two major kinase families— mitogen-activated protein kinases (MAPKs) and Adenosine 5‘-monophosphate-activated protein kinase (AMPK)—in the initiation, execution, and modulation of ferroptosis. We discuss how MAPK subfamilies, including extracellular signal-regulated kinase 1/2 (ERK1/2), c-Jun N-terminal kinase (JNK), p38 mitogen-activated protein kinase (p38), and extracellular signal-regulated kinase (ERK5), regulate iron metabolism, lipid peroxidation, and antioxidant responses through context-dependent signaling cascades. In parallel, AMPK acts as an energy-sensing hub that influences ferroptosis via lipid metabolic reprogramming and the control of glutathione peroxidase 4 (GPX4) expression. We further explore the dual implications of ferroptosis in tumor biology, highlighting its role as a barrier to cancer progression and the adaptive resistance mechanisms evolved by tumor cells. Finally, we evaluate the therapeutic potential of targeting kinase-mediated ferroptosis, offering insights into combination strategies involving kinase inhibitors and ferroptosis inducers, and addressing the challenges and future directions for translating these insights into clinical oncology.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: